[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Biochemistry](https://durgical.com/en/biochemistry/) › Tumour growth kinetics and the behaviour of cancer cells

# Tumour growth kinetics and the behaviour of cancer cells

How fast tumours grow, why they are found late, and which normal growth brakes cancer cells lose.

Updated Nov 16, 2026

## How to think about it

Tumour growth is a doubling clock that runs fastest while nobody can see it. About 30 silent doublings make the first centimetre; only about 10 more reach a lethal burden. Growth then slows (Gompertzian) as the tumour outgrows its blood supply and fewer cells divide. Chemotherapy kills a fixed fraction of cells per cycle and works best on dividing cells, so it works best when the tumour is small, after surgery, and when repeated.

## Key facts

- Doubling time, the time a tumour takes to double in size, ranges from days (some lymphomas and childhood tumours) to months or years (many carcinomas).
- About 30 doublings turn one cell into a tumour of about 1 cm (around 10⁹ cells), the size at which it is usually found; only about 10 more doublings reach a lethal mass.
- Growth is Gompertzian: fast while small, then slower as the tumour outgrows its blood supply and loses more cells.
- Normal cells stop dividing when they touch each other (contact inhibition) and need to be attached to divide (anchorage dependence); cancer cells lose both, pile up in layers and grow even in soft agar.
- Chemotherapy kills a constant fraction of cells with each cycle (log kill), and dividing cells are the most sensitive.

## Small or large tumour?

| Feature | Small (early or left after surgery) | Large (bulky, late) |
| --- | --- | --- |
| Growth fraction | High: most cells are dividing | Low: many cells resting or dying |
| Doubling time | Short | Longer (Gompertzian slowing) |
| Blood supply and oxygen | Good | Poor centre, hypoxia and necrosis |
| Sensitivity to chemotherapy | High | Lower |
| Resistant clones | Few | More likely to be present already |

## In detail

- The growth fraction is the share of tumour cells that are dividing; it is high in small tumours and falls as they grow.
- Repeated cycles, combinations of drugs and adjuvant treatment after surgery aim at a small tumour burden, when the growth fraction is high and fewer resistant cells exist.
- Oncofetal antigens are fetal proteins re-expressed by tumours: α-fetoprotein ([hepatocellular carcinoma](https://durgical.com/en/conditions/hepatocellular-carcinoma/), germ-cell tumours) and [carcinoembryonic antigen](https://durgical.com/en/biochemistry/topics/carcinoembryonic-antigen/) ([colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)).
- Tissue polypeptide antigen and related markers (TPS, CYFRA 21-1) are cytokeratin fragments released by proliferating epithelial tumour cells; they reflect proliferation but are not specific for any tumour.

**Also called**
Doubling time and Gompertzian growth, Contact inhibition and anchorage dependence

## Clinical notes

- Because a tumour has gone through most of its doublings before it can be felt or seen, screening aims to find it earlier.
- Tumour markers are best used to follow treatment and recurrence, not to screen healthy people.

## Common traps

- A tumour found at 1 cm has only just started: it has already gone through about 30 of the roughly 40 doublings to a lethal size, often years of silent growth.
- Each chemotherapy cycle removes a fixed number of cells: it removes a fixed fraction (log kill), so killing 99 % of 10¹¹ cells still leaves 10⁹, a tumour of detectable size.
- Large tumours grow fastest because they have the most cells: their growth fraction is lower and their doubling time longer; small tumours grow proportionally faster.
- A raised tumour marker in a healthy person means cancer: markers lack the sensitivity and [specificity](https://durgical.com/en/epidemiology/specificity/) for screening; they are mainly used to follow a known tumour.

## Test yourself

Think of the answer, then tap the question to see it.

## Why is a 1 cm tumour already «old»?

It has gone through about 30 of the roughly 40 doublings to a lethal size, so most of its life is already behind it.

## What does «log kill» mean in chemotherapy?

Each cycle kills a constant fraction of tumour cells, not a constant number, so repeated cycles are needed.

## A child with Burkitt lymphoma, which has a very short doubling time, starts chemotherapy and two days later has high potassium, phosphate and uric acid. Why?

A very high growth fraction makes the tumour exquisitely sensitive: huge numbers of cells die at once and release their contents ([tumour lysis syndrome](https://durgical.com/en/conditions/tumour-lysis-syndrome/)).

## After a breast cancer is completely removed, chemotherapy is given although no tumour can be seen. Why?

Any micrometastases are small, with a high growth fraction and few resistant cells, so log kill is most likely to eradicate them now.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/biochemistry/topics/tumour-growth-kinetics-and-the-behaviour-of-cancer-cells/)

## Connections

## Related conditions 2

- [Hepatocellular carcinoma](https://durgical.com/en/conditions/hepatocellular-carcinoma/)
- [Colorectal cancer](https://durgical.com/en/conditions/colorectal-cancer/)

## Related 4

- [Oncogenes and tumour suppressor genes](https://durgical.com/en/biochemistry/topics/oncogenes-and-tumour-suppressor-genes/)
- [Tumour markers: principles of use](https://durgical.com/en/biochemistry/topics/tumour-markers-principles-of-use/)
- [Alpha-fetoprotein (AFP)](https://durgical.com/en/biochemistry/topics/alpha-fetoprotein/)
- [Carcinoembryonic antigen (CEA)](https://durgical.com/en/biochemistry/topics/carcinoembryonic-antigen/)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: [What Is Cancer?](https://www.cancer.gov/about-cancer/understanding/what-is-cancer) (National Cancer Institute (NCI), 2026); [Tumor Markers](https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet) (National Cancer Institute (NCI), 2026).

[← All of biochemistry](https://durgical.com/en/biochemistry/)

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/biochemistry/topics/tumour-growth-kinetics-and-the-behaviour-of-cancer-cells/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/biochemistry/topics/tumour-growth-kinetics-and-the-behaviour-of-cancer-cells/
